ADx and Nipro have agreed to collaborate on the development of next-generation diagnostic tools for Alzheimer's disease. Together, the companies will focus on Point Of Care IVD products.
As Japan has one of the oldest populations worldwide, the country invests heavily in solutions for Alzheimer's. In this context, Nipro has a long standing experience in the development and commercialization of diagnostics and treatments of the disease.
Full press release: www.adxneurosciences.com/images/uploads/PR_ADx_-_Nipro_deal_12_October_2016_ENG.pdf